Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT00695409 · COMPLETED
Trial details
- NCT number
- NCT00695409
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-18
- Primary completion
- 2017-03-27
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.